Home » Topics » Regulatory » Patents

Patents
RSS

Chemerin receptor antagonists presented by Shenzhen Institute of Advanced Technology

Aug. 1, 2017

Bayer discloses soluble guanylate cyclase activators

Aug. 1, 2017

Sperovie Biosciences patents PDE4B and/or TNF-alpha release inhibitors

July 31, 2017

Adenosine A3 receptor antagonists identified at Handok

July 31, 2017

Guangzhou Henovcom Bioscience discovers FXR agonists

July 31, 2017

Sophia Bioscience divulges histone deacetylase inhibitors

July 31, 2017

Hua Medicine patents mGlu5 receptor antagonists

July 31, 2017

Mutant EGFR and/or HER2 inhibitors presented by Ancureall Biomedical Technology

July 31, 2017

Pfizer discloses dopamine D3 receptor ligands

July 28, 2017

ATR kinase inhibitors identified at Bayer Pharma

July 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...